Facts are stubborn but the desire to ignore them in the face of evidence should be inexcusable.
University Hospitals Cleveland Medical Center (UHCMC) cardiology interventionalists authored a new article in the Journal of the American College of Cardiology (JACC) entitled, “Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons,” (embargoed until March 5, 2 p.m.)
that is critical of the Center of Medicare and Medicaid (CMS) recent decision to not pay for drug-coated balloons despite their clinical superiority.
The CMS decided to end transitional pass through (TPT) add-on payment for drug-coated balloons at the first of the year without creating a new payment classification for the devices.
The outpatient hospital TPT add-on payment program is specifically designed to support patient access to new technologies that meet stringent criteria pertaining to clinical effectiveness.
Download full release